Vutrisiran in ATTR-CM: transforming outcomes with precision medicine

31 August 2025 (15:30 - 15:45)

Organised by:

About the speaker

Doctor Caroline Morbach

University Hospital Wuerzburg, Wuerzburg (Germany)

3 More presentations in this session

Presentation thumbnail

Welcome and introductions

Doctor E. Gonzalez Lopez (Madrid, ES)

Presentation thumbnail

RNAi therapeutics: revolutionising cardiovascular management

Doctor S. Cuddy (Boston, US)

Presentation thumbnail

Ask the experts – panel discussion and audience Q&A

Access the full session

Session thumbnail

RNAi therapeutics: changing the future landscape in ATTR-CM management

The Event

Event poster

ESC Congress 2025

31 August 2025 15:30 CET

You may be interested in

Congress Presentation

Transthyretin gene silencing therapy in Val50Met familial amyloid polyneuropathy with associated cardiomyopathy

11 May 2026

Congress Session

ATTRibutes of change: advances in treating and monitoring ATTR-CM

17 May 2025

Congress Presentation

Cardiac MRI as a possible alternative to echocardiography for therapeutic response monitoring in ATTR cardiomyopathy: a multiparametric evaluation in patisiran treated patients

11 May 2023

Congress Presentation

Effect of RNAi therapeutics patisiran and vutrisiran on orthostatic hypotension due to dysautonomia in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy

26 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources